Shea Jacqueline Elizabeth has filed 52 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 97240 shares of INOVIO PHARMACEUTICALS, INC. ($INO) on March 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | A | Common Stock Option | 97240 | $0.00 | 97,240.0000 | 53,571,675 | 9999.99% | 0.18% |
| March 4, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | A | Restricted Stock Unit | 78760 | $0.00 | 78,760.0000 | 53,571,675 | 9999.99% | 0.15% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 18632 | $0.00 | 78,317.0000 | 53,571,675 | 31.22% | 0.03% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 28401 | $0.00 | 98,661.0000 | 53,571,675 | 40.42% | 0.05% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 8057 | $1.79 | 70,260.0000 | 53,571,675 | 10.29% | 0.02% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 28401 | $0.00 | 56,800.0000 | 53,571,675 | 33.33% | 0.05% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 18632 | $0.00 | 18,631.0000 | 53,571,675 | 50.00% | 0.03% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 13657 | $1.79 | 85,004.0000 | 53,571,675 | 13.84% | 0.03% |
| May 20, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | A | Common Stock Option | 105262 | $0.00 | 105,262.0000 | 36,667,221 | 9999.99% | 0.29% |
| May 20, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | A | Restricted Stock Unit | 84888 | $0.00 | 84,888.0000 | 36,667,221 | 9999.99% | 0.23% |
| May 15, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 17744 | $0.00 | 17,744.0000 | 36,667,221 | 50.00% | 0.05% |
| May 15, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 7717 | $1.95 | 59,685.0000 | 36,667,221 | 11.45% | 0.02% |
| May 15, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 17744 | $0.00 | 67,402.0000 | 36,667,221 | 35.73% | 0.05% |
| May 10, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 2392 | $1.80 | 49,658.0000 | 36,667,221 | 4.60% | 0.01% |
| May 10, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 5500 | $0.00 | 52,050.0000 | 36,667,221 | 11.82% | 0.02% |
| May 10, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 5500 | $0.00 | 0.0000 | 36,667,221 | 100.00% | 0.02% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 18632 | $0.00 | 37,263.0000 | 0 | 33.33% | 0.00% |
| Feb. 27, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | A | Common Stock Option | 105649 | $0.00 | 105,649.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | A | Restricted Stock Unit | 85201 | $0.00 | 85,201.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 5852 | $0.00 | 39,499.0000 | 0 | 17.39% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 2493 | $1.98 | 37,006.0000 | 0 | 6.31% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 18632 | $0.00 | 55,638.0000 | 0 | 50.35% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 9088 | $1.98 | 46,550.0000 | 0 | 16.33% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 5852 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 15, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 17745 | $0.00 | 41,365.0000 | 0 | 75.13% | 0.00% |
| May 15, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 7718 | $13.07 | 33,647.0000 | 0 | 18.66% | 0.00% |
| May 15, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 17745 | $0.00 | 35,488.0000 | 0 | 33.33% | 0.00% |
| May 10, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 5500 | $0.00 | 26,012.0000 | 0 | 26.81% | 0.00% |
| May 10, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 2392 | $10.65 | 23,620.0000 | 0 | 9.20% | 0.00% |
| May 10, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 5500 | $0.00 | 5,500.0000 | 0 | 50.00% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 5853 | $0.00 | 5,852.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | A | Common Stock Option | 69733 | $0.00 | 69,733.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | A | Restricted Stock Unit | 55895 | $0.00 | 55,895.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 1878 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 2856 | $8.16 | 20,512.0000 | 0 | 12.22% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 5853 | $0.00 | 23,368.0000 | 0 | 33.42% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 872 | $8.16 | 17,515.0000 | 0 | 4.74% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 1878 | $0.00 | 18,387.0000 | 0 | 11.38% | 0.00% |
| May 15, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | A | Restricted Stock Unit | 638800 | $0.00 | 638,800.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 28704 | $0.81 | 198,113.0000 | 0 | 12.66% | 0.00% |
| May 10, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 66000 | $0.00 | 132,000.0000 | 0 | 33.33% | 0.00% |
| May 10, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 66000 | $0.00 | 226,817.0000 | 0 | 41.04% | 0.00% |
| March 11, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 59737 | $0.00 | 186,797.0000 | 0 | 47.01% | 0.00% |
| March 11, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 25980 | $1.13 | 160,817.0000 | 0 | 13.91% | 0.00% |
| March 11, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 59737 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 22544 | $0.00 | 99,099.0000 | 0 | 29.45% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Common Stock | 70234 | $0.00 | 159,545.0000 | 0 | 78.64% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 32485 | $1.28 | 127,060.0000 | 0 | 20.36% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 22544 | $0.00 | 22,544.0000 | 0 | 50.00% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | M | Restricted Stock Unit | 70234 | $0.00 | 140,466.0000 | 0 | 33.33% | 0.00% |
| Feb. 27, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | A | Common Stock Option | 836800 | $0.00 | 836,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Shea Jacqueline Elizabeth | Chief Executive Officer | F | Common Stock | 9788 | $1.28 | 89,311.0000 | 0 | 9.88% | 0.00% |